Home / PIGA Knockout Cell Lines

PIGA Knockout Cell Lines

Gene: PIGA

Official Full Name: phosphatidylinositol glycan anchor biosynthesis class Aprovided by HGNC

Gene Summary: This gene encodes a protein required for synthesis of N-acetylglucosaminyl phosphatidylinositol (GlcNAc-PI), the first intermediate in the biosynthetic pathway of GPI anchor. The GPI anchor is a glycolipid found on many blood cells and which serves to anchor proteins to the cell surface. Paroxysmal nocturnal hemoglobinuria, an acquired hematologic disorder, has been shown to result from mutations in this gene. Alternate splice variants have been characterized. A related pseudogene is located on chromosome 12. [provided by RefSeq, Jun 2010]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00869 PIGA Knockout cell line (K-562) Human PIGA 1:3-1:5 Negative Online Inquiry
KO01004 PIGA Knockout cell line (THP-1) Human PIGA 1:2-1:4 Negative Online Inquiry
KO15143 PIGA Knockout cell line (HeLa) Human PIGA 1:3~1:6 Negative Online Inquiry
KO15144 PIGA Knockout cell line (HCT 116) Human PIGA 1:2~1:4 Negative Online Inquiry
KO15145 PIGA Knockout cell line (HEK293) Human PIGA 1:3~1:6 Negative Online Inquiry
KO15146 PIGA Knockout cell line (A549) Human PIGA 1:3~1:4 Negative Online Inquiry

Background

PIGA Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack functional Phosphatidylinositol Glycan Anchor Biosynthesis Class A (PIGA) gene expression. The PIGA gene plays a critical role in the biosynthesis of glycosylphosphatidylinositols (GPIs), which are essential for anchoring numerous proteins to the cell surface. The knockdown of this gene leads to the disruption of GPI anchor synthesis, which serves as a crucial mechanism to study various cellular processes, including cell signaling, adhesion, and immune responses.

These cell lines function as valuable tools for researchers aiming to investigate the role of GPIs in cellular physiology and the pathogenesis of diseases such as Paroxysmal Nocturnal Hemoglobinuria (PNH) and certain cancers. By employing CRISPR-Cas9 or other gene editing technologies, the PIGA gene knockout allows for detailed analysis of cellular responses in the absence of GPI-anchored proteins, facilitating insights into how these alterations affect health and disease.

The scientific importance of PIGA Gene Knockout Cell Lines is underscored by their application in both basic and applied research. They enable the exploration of therapeutic targets and potential intervention strategies for conditions linked to dysregulated GPI-anchored proteins. Compared to alternative cell lines, these knockout lines provide a more precise model system for studying the specific contributions of GPI-anchored proteins without interference from functional variants, making them indispensable for high-quality, reproducible results.

For researchers and clinicians, the advantages of using PIGA Gene Knockout Cell Lines extend beyond their experimental utility; they represent an opportunity to accelerate the discovery of novel therapeutic approaches and enhance the understanding of GPI-related pathologies. Such insights not only propel scientific development but also pave the way for innovative clinical applications.

Our company prides itself on its expertise in developing high-quality, genetically engineered cell lines, catering to the evolving needs of the scientific community. With a commitment to precision and reliability, we ensure that our PIGA Gene Knockout Cell Lines are a valuable addition to your research toolkit, promising to enhance both understanding and therapeutic options in the realm of cellular biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.